Product category:
Lab automation equipment and robotics
News Release from: Velocity11 | Subject: BioCel 1200
Edited by the Laboratorytalk Editorial
Team on 13 October 2005
The next level in compact, affordable
automation
Said to be the most compact system capable of automating applications from compound plate replication and HTS assays in drug discovery to nucleic acid sample preparation in genomics laboratories
Velocity-11 has introduced the BioCel 1200, the company's newest automated sample processing platform With a footprint of just 2x1.2m, the BioCel 1200 is said to be the most compact system on the market that is capable of automating a wide range of applications, spanning from compound plate replication and HTS assays in drug discovery research to nucleic acid sample preparation in genomics laboratories
This article was originally published on Laboratorytalk on 11 Jul 2008 at 8.00am (UK)
Related stories
Reference guide covers optimal microplate sealing
The free-of-charge reference guide will be of interest to both those currently sealing microplates or those thinking about investing in a microplate sealing instrument
Discovery stimulated by automated compound library
Echnical poster describes a high throughput plate and tube sample processing system installed by Velocity11 at the Eskitis Institute for Cell and Molecular Therapies, Griffith University, Australia
The BioCel 1200 is the latest addition to the BioCel family of automation platforms, cliaming unprecedented compactness, flexibility, expandability, speed and affordability.
The unique design of the BioCel 1200 utilises the reliable high-speed central robot found in the BioCel 1600, with the new capability of robotic reach outside of the system frame.
This feature, combined with the use of space-saving sliding doors, permits the flexibility to easily integrate large readers, compound stores or other devices into the system.
The new design also enables future expandability by combining multiple units with plug-and-play simplicity.
The BioCel 1200 is operated with Velocity-11's VWorks automation control software.
Its dynamic scheduling capabilities and innovative error recovery technology are just some of the reasons why VWorks is fast becoming a standard for controlling a wide range of automation systems at the world's leading pharmaceutical and biotechnology companies, says the company.
Pre-introduction orders for the BioCel 1200 system have been taken and the first unit is being installed this month (October 2005) to a major European pharmaceutical company.
Velocity-11 is privately held and focused on pioneering automation technology for life science laboratories.
The company says its customers comprise most of the major pharmaceutical and biotechnology companies as well as leading genome centres and academic institutions.
• Velocity11: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
